CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Enzymatic has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Enzyme Solutions Providers - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Suzanne Scarlata, Co-founder, Inventor & Consultant.

Enzymatic
Sustainable Concrete Solutions through Enzyme Innovation

Enzymatic

Suzanne Scarlata, Enzymatic | Life Science Review | Top Enzyme Solutions ProvidersSuzanne Scarlata, Co-founder, Inventor & Consultant; Nima Rahbar, Co-founder, Inventor & Consultant
When Suzanne Scarlata, a skilled biochemist, and Nima Rahbar, a civil engineering professor, crossed paths at Worcester Polytechnic Institute (WPI), little did they know it would result in a revolutionary product. Their conversation about the Dutch experimenting with microbes in concrete sparked a groundbreaking approach to concrete treatments using isolated enzymes.

Early on, the duo recognized that the Dutch concept was great in theory but held practical challenges. With the help of graduate students, Scarlata and Rahbar explored the use of isolated enzymes for regular treatment, which were found to be more practical and effective. This caught the attention of Charlie Maddox, who joined as a co-founder and CEO of their new venture, Enzymatic.

With Scarlata and Rahbar leading as consultants, Enzymatic embarked on a journey toward greener and self-healing structures.

Its core focus revolves around developing green solutions for concrete, particularly with the use of a derivative of carbonic anhydrase, an enzyme that is present in all living things. Enzymatic’s solution repairs micro-cracks in concrete and acts as a protective shield against harmful substances such as chloride ions. This highly effective, self-healing property enables ordinary concrete to last up to four times longer.

“Our solution enhances the durability of concrete, contributing to its resilience and longevity while also embodying a shift toward sustainable infrastructures through advanced technologies,” says Suzanne Scarlata, co-founder, inventor and consultant.

The concrete industry contributes almost eight percent of all greenhouse gas emissions. Enzymatic’s carbon-neutral structural material offers strength and durability while significantly reducing emissions.

Testing is being conducted to improve the material’s endurance under water, and for expanding its applications. For example, roof tiles made using this material will enhance the energy storage capacities of solar panels due to the minimal maintenance requirements.

Enzymatic’s commitment to enhancing the strength and stability of building materials across varied environmental conditions adds depth to its focus on green concrete. The innovative additive is known for its remarkable ability to extend the life of concrete and prevent corrosion.

The company has also tested its new additive—a corrosion inhibitor using the carbonic anhydrase enzyme. While production is still in its early stages, it has set up facilities in Puerto Rico for large-scale manufacturing.

The ability to withstand extreme conditions makes its products suitable for a wide range of applications in the construction industry.

Our Solution Enhances The Durability Of Concrete, Contributing To Its Resilience And Longevity While Also Embodying A Shift Toward Sustainable Infrastructures Through Advanced Technologies


The response from industry leaders has been overwhelmingly positive, particularly from cement and concrete companies, who see the value in adopting Enzymatic’s solutions. Besides the financial benefits of low maintenance, there is a shared commitment to environmental stewardship and sustainable development.

Enzymatic’s vision extends beyond improving concrete. It is dedicated to making its solutions accessible to everyone, including builders and homeowners. This goal has the potential to make sustainable construction practices the norm rather than the exception. The company is in the process of partnering with leading retailers to fulfill this vision.

Its pioneering solution showcases a forward-thinking ethos that aims to establish a resilient, efficient and sustainable built environment. Enzymatic’s unwavering dedication to sustainable practices has positively impacted the construction industry, making it more eco-friendly.

Top 10 Enzyme Solutions Providers - 2024
Current Issue

Company : Enzymatic

Management
Suzanne Scarlata, Co-founder, Inventor & Consultant; Nima Rahbar, Co-founder, Inventor & Consultant

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/enzymatic